AUD

India's BNPL Future Looks Bright: User Base Expected to Quintuple to Surpass 100 Million by 2027

Retrieved on: 
Monday, September 18, 2023

DUBLIN, Sept. 18, 2023 /PRNewswire/ -- Buy Now, Pay Later (BNPL) services are rapidly gaining trust and popularity among consumers in the Asia-Pacific (APAC) region, according to a recent publication. More adults in the APAC region completely trust BNPL services rather than completely distrusting them, setting the stage for significant growth in BNPL adoption. BNPL has also become one of the top 7 payment methods used at least 5 times per month in the region.

Key Points: 
  • BNPL Industry and Trends Overview, June 2023
    Overview of BNPL Concerns and Regulations, June 2023
    Share of BNPL Accounting for Total B2C E-Commerce Transaction Value, in %, 2022
    Payment Methods Used At Least 5 Times Per Month, in % of Respondents, September 2022
    Market Shares of BNPL Services, in % of Top B2C E-Commerce Websites Supporting BNPL as a Payment Method, March 2023
    Overview of Apple Pay Later, June 2023
    Overview of Klarna's Activities in BNPL Landscape, June 2023
    Number of Afterpay's Active Users, in millions, & Year-on-Year Change, in %, December 2019, December 2020, December 2021, March 2022
    Number of Afterpay's Active Sellers, in thousands, & Year-on-Year Change, in %, December 2019, December 2020, December 2021, March 2022
    Number of Affirms's Active Users, in millions, & Year-on-Year Change, in %, June 2019-2022
    Share of BNPL Accounting for Total B2C E-Commerce Payments, in %, 2022 & 2026f
    Payment Methods Used At Least 5 Times Per Month, in % of Respondents, September 2022
    Top Product Categories Purchased on Online B2C E-Commerce Site Zalora Using BNPL, in % of BNPL Payments, Q3 2022
    Breakdown of Payment Methods Used to Purchase Luxury on Online B2C E-Commerce Site Zalora, in %, 2021 & 2022
    Breakdown of Payments Used on Online B2C E-Commerce Site Zalora, by Age Group, in % of Online Shoppers, Q3 2022
    BNPL Usage, by Age, in % of Internet Users, 2022e
    Share of Respondents Using BNPL, in %, December 2022
    Level of Usage of Buy Now Pay Later Services Compared to a Year Ago, in % of BNPL Users, December 2022
    Breakdown of Total Transaction Value vs Volume, in %, FY 2022
    Breakdown of BNPL Revenue, by Age, in % of BNPL Users, February 2023
    Level of Concern/Stress Over Type Debt, by Type of Debt, incl.
  • BNPL Loan, Q4 2022
    Current Outstanding Balances on Loans in Capital City, in AUD thousand, Q4 2022
    BNPL vs Credit & Debit Card Transaction Value, in SGD billion, 2021
    Breakdown of BNPL User Age, in %, April 2022
    Breakdown of BNPL Users Aged 25 or Older Accounting for Total BNPL Transaction Value, in %, April 2022

Pellycan Asphalt Awarded a 2023 Global Recognition Award(TM)

Retrieved on: 
Thursday, September 7, 2023

New York, New York--(Newsfile Corp. - September 7, 2023) - In a resounding acknowledgment of corporate excellence and innovation, Pelly-Can Asphalt and its Founders, Daniel Mikus and James & Jessica Rolph, have received the prestigious 2023 Global Recognition Award .

Key Points: 
  • New York, New York--(Newsfile Corp. - September 7, 2023) - In a resounding acknowledgment of corporate excellence and innovation, Pelly-Can Asphalt and its Founders, Daniel Mikus and James & Jessica Rolph, have received the prestigious 2023 Global Recognition Award .
  • Rather than adhering to conventional business paths, Pelly-Can Asphalt embraces an exceptionally distinctive approach.
  • The Global Recognition Awards, a celebration of excellence in business and innovation, found Pelly-Can Asphalt and its founders Daniel Mikus James & Jessica Rolph entirely deserving of this year's recognition due to their blueprint for success.
  • Alex Sinclair from Global Recognition Awards noted, "Pelly-Can Ashphalt's unprecedented growth, market disruption, and reputation for securing major contracts exemplify why they have earned this accolade."

Immuron achieves record monthly Travelan® sales

Retrieved on: 
Wednesday, September 13, 2023

MELBOURNE, Australia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record monthly sales (unaudited net sales) of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.

Key Points: 
  • MELBOURNE, Australia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record monthly sales (unaudited net sales) of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.
  • Immuron has since supplied product to wholesalers who in turn have supplied retail pharmacies.
  • Sales of Travelan® increased by 7984% in August 2023 to AUD $1.18 M, compared to AUD $14,581 in August 2022.
  • Immuron anticipates sales to grow strongly closer to the peak spring / summer travel period.

Archblock Announces Rebranding of Stablecoin Portfolio

Retrieved on: 
Tuesday, September 12, 2023

Archblock , enabling open access to financial opportunities and global trade, is thrilled to announce the rebranding of its portfolio of stablecoins, previously known as TrueCoin.

Key Points: 
  • Archblock , enabling open access to financial opportunities and global trade, is thrilled to announce the rebranding of its portfolio of stablecoins, previously known as TrueCoin.
  • The Archblock Stablecoins portfolio features fiat-backed stablecoins pegged to the GBP, CAD and AUD.
  • In addition to its portfolio of stablecoins, Archblock Stablecoins offers the technical and operational foundation to build white-label stablecoins for others.
  • Archblock launched the first institutional-grade fiat-backed stablecoin, TrueUSD (“TUSD”), in 2018 as a proof of concept in asset-backed token development.

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder

Retrieved on: 
Wednesday, September 6, 2023

"We are honored to collaborate with JHU for our first in human clinical trial.

Key Points: 
  • "We are honored to collaborate with JHU for our first in human clinical trial.
  • "Johns Hopkins is our second US clinical site joining our trial, following Yale School of Medicine’s Department of Psychiatry.
  • The patients will report their drinking patterns and craving for alcohol (and cigarettes) during the clinical trial period.
  • CM-CMND-001 clinical trial is a multinational, multi-center, Phase I/II single- and multiple-dose tolerability, safety and pharmacokinetic study in healthy volunteers and AUD subjects.

MR Roads Founders Hit AUD 13 Million Revenue Milestone in First Year

Retrieved on: 
Monday, September 4, 2023

Queensland, Australia--(Newsfile Corp. - September 4, 2023) - Asphalt contracting company MR Roads has achieved a revenue milestone of $13 Million AUD in its first year of operation.

Key Points: 
  • Queensland, Australia--(Newsfile Corp. - September 4, 2023) - Asphalt contracting company MR Roads has achieved a revenue milestone of $13 Million AUD in its first year of operation.
  • MR Roads offers a range of asphalt contracting services, including paving, resurfacing, and maintenance.
  • MR Roads is also the partner of choice for full-service roadworks as part of Brisbane's exciting new Cross River Rail project.
  • This unique approach, combined with a relentless focus on client satisfaction, has allowed MR Roads to grow from $100,000 to $13 Million AUD in one year.

COROS announces the PACE 3 GPS Sport Watch

Retrieved on: 
Tuesday, August 29, 2023

IRVINE, Calif., Aug. 29, 2023 /PRNewswire/ -- COROS Wearables Inc., makers of GPS sports wearables and training software for multi-sport athletes, today announced the launch of the PACE 3, its latest performance-focused sport wearable and successor to The PACE 2, which packs an even more powerful punch.

Key Points: 
  • IRVINE, Calif., Aug. 29, 2023 /PRNewswire/ -- COROS Wearables Inc., makers of GPS sports wearables and training software for multi-sport athletes, today announced the launch of the PACE 3 , its latest performance-focused sport wearable and successor to The PACE 2, which packs an even more powerful punch.
  • Improving on its legendary predecessor in every way, the COROS PACE 3 includes:
    - Next-Generation GPS – A redesigned All Systems satellite chipset with optional Dual Frequency will keep your GPS data accurate, even in the most challenging circumstances, like high-rise cities or deep within the forest.
  • COROS PACE 3 provides an extensive range of activity modes that are optimized for accurate measurement.
  • The COROS PACE 3 Track Edition will be available to order from COROS.com in October 2023.

Unmasking the Drinking Culture: Alcohol Abuse vs. Social Drinking

Retrieved on: 
Tuesday, August 29, 2023

LAKE WORTH, Fla., Aug. 29, 2023 /PRNewswire/ -- Drinking to excess is well-tolerated and even encouraged in American culture. Alcohol is used to celebrate, soothe disappointments, relax, and enhance social gatherings. Imbibing fine wines and craft cocktails is symbolic of enjoying the finer things in life.

Key Points: 
  • However, the widely accepted practice of having "one too many" blurs the lines between potentially dangerous alcohol abuse and responsible social drinking.
  • Understanding the difference between alcohol abuse, alcohol use disorder, and social drinking is integral to understanding personal drinking habits.
  • Alcohol abuse does not always lead to alcohol use disorder, but it is one of the first steps toward addiction.
  • The National Institute on Alcohol Abuse and Alcoholism (NIAA) defines alcohol abuse as continuing to drink despite experiencing consequences from your alcohol use.

Leviathan Gold enters into Heads of Agreement in regard to the Excelsior Prospect at its Avoca Project.

Retrieved on: 
Tuesday, August 29, 2023

Historic production records from Excelsior indicate the mining of 13,200 tons for 9,260 ounces of gold from an ore shoot to a depth of 100 meters.

Key Points: 
  • Historic production records from Excelsior indicate the mining of 13,200 tons for 9,260 ounces of gold from an ore shoot to a depth of 100 meters.
  • VANCOUVER, BC, Aug. 29, 2023 /PRNewswire/ - Leviathan Gold Ltd. ("Leviathan", the "Company") (TSXV: LVX) (Germany: 0GP) is pleased to announce that its wholly-owned subsidiary, Leviathan Gold (Australia) Pty Ltd., has entered into Heads of Agreement ("HOA") with Core Prospecting Pty Ltd. ("Core") in regard to the Excelsior Prospect at its Avoca Project in the Victorian goldfields, Australia.
  • Upon fulfilment of certain conditions by Core, Leviathan shall on behalf of Core apply for a standalone tenure over the AOI, (the "New Tenement").
  • If Core fails to complete Phase 2 they shall forfeit any interest under Phase 1 and shall have no interest in the AOI.

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism

Retrieved on: 
Monday, August 28, 2023

Session 11: Treatment of alcohol use disorder: safety and efficacy of precision medicine in selected patients

Key Points: 
  • Session 11: Treatment of alcohol use disorder: safety and efficacy of precision medicine in selected patients
    The presentations will discuss new approaches in the treatment of Alcohol Use Disorder (AUD), specifically developing a targeted approach through precision medicine.
  • Precision medicine incorporates the genetic, environmental, and lifestyle factors of an individual to tailor a treatment that would be efficacious for that patient.
  • “Presenting at this congress provides us with the opportunity to increase awareness of the significant need for additional treatments for patients with AUD.
  • Emphasizing the development of innovative therapies rooted in precision medicine to address alcohol cravings and excessive consumption promotes the recognition of the necessity for diverse treatments for this condition,” said Dr. Johnson.